HLYK HealthLynked Corp
Services-Offices & Clinics of Doctors of Medicine · OTC · SEC CIK 1680139 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-52.0%
TTM net income YoY-4.5%
TTM EPS YoY1.5%
Revenue 3-yr CAGR-43.1%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-202.3%
Net margin-351.6%
FCF margin—
EBITDA margin-196.7%
Returns
ROE—
ROA-234.0%
ROIC (approx.)—
Asset turnover0.67x
Leverage & solvency
Liabilities / assets641.2%
Debt / equity—
Current ratio0.52x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.35x
Accruals ratio-153.2%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2.07M | $3.01M | $5.72M | $5.86M | $6.50M |
| SG&A expense | $2.04M | $3.04M | $3.62M | $4.58M | $4.93M |
| Operating income | -$2.11M | -$4.68M | -$4.15M | -$8.66M | -$5.33M |
| Interest expense | — | — | $21,331 | $0 | — |
| Pretax income | -$3.28M | -$6.13M | -$3.61M | -$8.07M | -$10.70M |
| Net income | -$3.28M | -$6.13M | -$1.01M | -$8.82M | -$10.41M |
| EBITDA | -$2.01M | -$4.39M | -$3.80M | -$7.83M | -$4.50M |
| EPS (basic) | -1.16 | -2.18 | 0.00 | -0.04 | -0.05 |
| EPS (diluted) | -1.16 | -2.18 | 0.00 | -0.04 | -0.05 |
| Weighted avg. shares (diluted) | 2.84M | 2.82M | 262.89M | 243.42M | 224.66M |
| Balance sheet | |||||
| Cash & equivalents | $37,136 | $76,241 | $247,222 | $61,891 | $3.29M |
| Receivables | — | — | $20,861 | $72,284 | $86,287 |
| Inventory | $17,962 | $44,686 | $133,222 | $192,833 | $134,930 |
| Current assets | $1.55M | $1.64M | $656,160 | $2.14M | $3.65M |
| PP&E, net | $74,705 | $176,576 | $290,755 | $413,123 | $350,482 |
| Goodwill | — | — | — | $319,958 | $766,249 |
| Intangibles | — | — | $883,848 | $1.11M | $3.81M |
| Total assets | $1.70M | $2.22M | $4.28M | $4.58M | $10.69M |
| Current liabilities | $7.01M | $4.69M | $2.41M | $3.47M | $1.92M |
| Short-term debt | — | — | — | $450,000 | $450,000 |
| Long-term debt | — | — | — | $45,000 | $101,250 |
| Total debt | — | — | — | $495,000 | $551,250 |
| Total liabilities | $7.46M | $5.35M | $3.48M | $4.27M | $3.49M |
| Shareholders' equity | -$5.76M | -$3.13M | $804,730 | $314,450 | $7.20M |
| Net debt | — | — | — | $433,109 | -$2.74M |
| Shares outstanding | 2.88M | 2.82M | 275.96M | 255.94M | 237.89M |
| Cash flow statement | |||||
| Operating cash flow | -$1.71M | -$3.49M | -$4.14M | -$4.36M | -$3.77M |
| Capital expenditure | — | $2,598 | $1,500 | $23,564 | $19,250 |
| Free cash flow | — | -$3.50M | -$4.15M | -$4.39M | -$3.79M |
| Investing cash flow | $125,000 | $422,402 | $3.51M | -$544,750 | -$341,356 |
| Financing cash flow | $1.55M | $2.90M | $824,087 | $1.68M | $7.24M |
| Depreciation & amortization | $101,871 | $282,950 | $352,027 | $829,481 | $827,696 |
| Stock-based compensation | $158,625 | $210,333 | $303,979 | $100,000 | — |
| Share buybacks | — | — | — | — | $7,700 |
Free plan shows the latest 5 periods; Pro shows all 10 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.